Zilia announced today that it received FDA 510(k) clearance for its Ocular FC retinal camera for non-invasive ocular assessments. Quebec City, Canada-based Zilia designed the Ocular FC system for assessing ocular biomarkers. The company believes it could “transform the diagnosis and management of ocular diseases,” according to a news release. It said the FDA clearance […]
Optical/Ophthalmic
Alcon stock dips on Q3 misses, tightened guidance
Alcon shares fell this morning on third-quarter results that missed the consensus forecast. Shares of ALC dipped 6.9% at $69.82 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1%. The Geneva, Switzerland–based eye care device company posted profits of $204 […]
iStar Medical continues European MINIject rollout with first procedures in Ireland
iStar Medical announced today that it expanded the commercial rollout of its MINIject device with the first implants in Ireland. MINIject, a minimally invasive glaucoma surgery (MIGS) device, treats open-angle glaucoma. Currently the only commercially available supraciliary MIGS implant, it has demonstrated meaningful and sustained performance, plus a favorable safety profile. The device combines the […]
FDA issues warning about over-the-counter eye drops
The FDA issued a notice warning consumers about 26 over-the-counter eye drop products that could result in eye infections. In its notice, the FDA instructed consumers not to purchase and to immediately stop using these products. Using those eye drops could lead to the risk of infections that could result in partial vision loss or […]
Pixium Vision looks for a buyer
Pixium Vision this week said it launched a tender process for the purpose of finding buyers to acquire the company’s business. The company has been unable to find financial investors within the restricted timeframe and in line with Pixium Vision’s needs. Pixium Vision is requesting the conversion of safeguard proceedings into receivership. The deadline for […]
Baxter launches image capture capability for PanOptic Plus ophthalmoscope
Baxter (NYSE:BAX) announced today that it launched a digital image capture capability for eye exams using its existing ophthalmoscope. Deerfield, Illinois-based Baxter added the iExaminer Pro system to its Welch Allyn PanOptic Plus ophthalmoscope. The scope came to Baxter through its $12.5 billion acquisition of Hillrom in 2021. The system adds a key technology to […]
Bausch+Lomb launches $1.4B offering to finance XIIDRA eye drop buy
Bausch + Lomb (NYSE:BLCO) announced today that it launched an offering worth $1.4 billion in new senior secured notes. The company intends to offer the notes, due 2028, and to enter into an incremental term loan facility. Both moves aim to support the financing of the company’s pending acquisition of XIIDRA. Bausch + Lomb expects […]
Zeiss to unveil new intraocular lens, other ophthalmic tech
Zeiss Medical Technology intends to unveil new ophthalmic innovations within its cataract and corneal refractive workflows. The Carl Zeiss Meditec unit plans to showcase these technologies at the European Society of Cataract and Refractive Surgery conference next month. As part of its ecosystem, the new offerings bolster Zeiss’ leadership position in ophthalmic diagnostic and surgical […]
Staar Surgical, NFL QB Will Levis team up to promote implantable collamer lenses
Staar Surgical (Nasdaq:STAA) announced today that it partnered with Tennessee Titans quarterback Will Levis to promote the EVO ICL. EVO Implantable Collamer lenses (ICLs) work in harmony with the natural eye to provide clear vision without causing dry eye. The FDA-approved lenses correct myopia, which affects distance vision, and myopia with astigmatism, which causes blurred […]
Eyenovia makes first sale of drug-device combo for pupil dilation
Eyenovia (Nasdaq:EYEN) today announced the first commercial sale of Mydcombi, its eye treatment for use with the Optejet delivery device. In May, the FDA approved the Mydcombi treatment for use with Optejet. New York-based Eyenovia designed Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where short-term […]
Glaukos beats Wall Street sales expectations in Q2
Glaukos (NYSE:GKOS) shares posted second-quarter financial results that came in well ahead of the consensus revenue forecast. Shares of GKOS remained relatively unmoved at $74.72 apiece after the market closed today. The Aliso Viejo–based ophthalmic medical technology company posted losses of $32.8 million. That amounts to 68¢ per share on sales of $80.4 million for […]
